De Novo Drug Design

De novo drug design aims to create entirely new drug molecules from scratch, accelerating and improving the drug discovery process. Current research heavily utilizes generative AI models, including diffusion models, recurrent neural networks, transformers, and variational autoencoders, often coupled with reinforcement learning algorithms to optimize molecule properties and explore chemical space more efficiently. These methods are being applied to both small molecule and protein generation, focusing on improving molecular validity, target specificity, and desired pharmacological properties. The ultimate goal is to significantly reduce the time and cost associated with drug development, leading to faster and more effective treatments for various diseases.

Papers